Rans K, Goffin K, Joniau S, Daugaard G, et al. The impact of progression-directed therapy on survival in metastatic castration-refractory prostate cancer: MEDCARE phase 3 trial. BJU Int 2024 Nov 6. doi: 10.1111/bju.16574.
PMID: 39506181